Covestro's Final Act: Squeeze-Out Locks Stock Near Compensation Level as Legal Challenges Loom

Covestro shares hover at €59.60, just above the cash compensation of €59.46, as minority squeeze-out nears completion. Legal challenges and operational shifts mark the final chapter.

Covestro shares have all but shed their industrial identity, trading as a pure compensation instrument as the chemicals group barrels toward its final delisting. On Friday, the stock edged down 0.17 percent to €59.60, a whisker above the €59.46 cash compensation approved by shareholders on May 19 for the full transfer of minority stakes to XRG. The annualized monthly volatility has collapsed to 1.48 percent, reflecting a market pricing in little more than the mechanics of the exit.

The decision to halt dividends for 2025 had already been flagged following a €644 million net loss in 2024 on revenue of €12.9 billion. On the day of the annual meeting, the stock closed at €59.70, just €0.24 above the appraised exit price. The 50-day moving average of €59.71 underscores how tightly the stock is pinned to the compensation figure, with the 52-week high of €61.00 now 2.13 percent away and the low of €54.62 nearly 10 percent below.

The squeeze-out resolution sailed through with 96.16 percent of the share capital, clearing the path for XRG and its subsidiaries — already holding 95.1 percent of the enlarged capital, or 197.7 million shares — to mop up the remainder. A capital increase earlier raised gross proceeds of €1.17 billion for the company. Xetra trading was halted at the end of 2025, leaving only the Frankfurt Stock Exchange as the venue for the few remaining minority holders.

Investors focused on the gap between the earlier takeover offer of €62.00 and the final compensation of €59.46, a spread of €2.54 per share that has drawn legal attention. The appraisal was prepared by PricewaterhouseCoopers, but its adequacy can be challenged in a court-supervised Spruchverfahren (appraisal proceeding) once the squeeze-out is formally registered. Law firm ARENDTS ANWÄLTE has already announced it will represent minority shareholders in such a proceeding, seeking a possible top-up payment rather than a reversal of the transfer.

The legal clock starts ticking only after the Covestro AG entry in the commercial register. Until then, the current stock price remains anchored by the compensation floor. A successful appraisal could unlock a modest additional payout — enough to keep the stock from decaying toward pure cash value while the process plays out.

Beneath the legal maneuvering, Covestro continues to execute on operational and strategic shifts. In August 2025, it agreed to acquire Vencorex’s sites in Thailand and the United States, with completion targeted for the first half of 2026. At the Dormagen plant, a new compressor facility backed by new owner ADNOC is expected to save more than 40,000 tonnes of CO? annually, with construction starting by end-2026 and start-up mid-2027. The STRONG efficiency program had already delivered €275 million in savings by the end of last year, with a target of €400 million by 2028.

At the same time, the leadership is being reshuffled. CEO Markus Steilemann will not extend his contract beyond May 2028, and CFO Christian Baier is departing in September. The supervisory board must now reorganize the executive suite while the integration of XRG, the efficiency drive, and the portfolio overhaul all remain in progress.

For the remaining minority, the dividend yield is now a relic. The only question that matters is when the commercial register entry triggers the automatic payout — and whether a subsequent appraisal proceeding will rewrite the final value of their Covestro shares. The spread of €2.54 may be modest, but for a stock trading within arm’s length of its floor, it is the only source of upside left.